-
1
-
-
0031059782
-
The pharmacokinetics and pharmacodynamics of adinazolam: Multi-ethnic comparisons
-
K. Ajir, M. Smith, K.M. Lin, J.C. Fleishaker, J.H. Chambers, D. Anderson, I. Nuccio, Y. Zheng, and R.E. Poland The pharmacokinetics and pharmacodynamics of adinazolam: multi-ethnic comparisons Psychopharmacology 129 1997 265 270
-
(1997)
Psychopharmacology
, vol.129
, pp. 265-270
-
-
Ajir, K.1
Smith, M.2
Lin, K.M.3
Fleishaker, J.C.4
Chambers, J.H.5
Anderson, D.6
Nuccio, I.7
Zheng, Y.8
Poland, R.E.9
-
4
-
-
0030698705
-
Blood clozapine levels elevated by fluvoxamine: Potential for side effects and lower clozapine dosage
-
S. Armstrong, and J.R. Stephens Blood clozapine levels elevated by fluvoxamine: potential for side effects and lower clozapine dosage J. Clin. Psychiatry 58 1997 499
-
(1997)
J. Clin. Psychiatry
, vol.58
, pp. 499
-
-
Armstrong, S.1
Stephens, J.R.2
-
5
-
-
0028902662
-
Cytochrome P34502D6 genotype does not determine response to clozapine
-
M.J. Arranz, E. Dawson, S. Shaikh, P. Sham, T. Sharma, K. Aitchison, M.A. Crocq, M. Gill, R. Kerwin, and D.A. Collier Cytochrome P34502D6 genotype does not determine response to clozapine Br. J. Clin. Pharmacol. 39 1995 417 420
-
(1995)
Br. J. Clin. Pharmacol.
, vol.39
, pp. 417-420
-
-
Arranz, M.J.1
Dawson, E.2
Shaikh, S.3
Sham, P.4
Sharma, T.5
Aitchison, K.6
Crocq, M.A.7
Gill, M.8
Kerwin, R.9
Collier, D.A.10
-
6
-
-
0027321081
-
Tissue concentrations of clozapine and its metabolites in the rat
-
R.J. Baldessarini, F. Centorrino, J.G. Flood, S.A. Volpicelli, D. Huston-Lyons, and B. Cohen Tissue concentrations of clozapine and its metabolites in the rat Neuropsychopharmacology 9 1993 117 124
-
(1993)
Neuropsychopharmacology
, vol.9
, pp. 117-124
-
-
Baldessarini, R.J.1
Centorrino, F.2
Flood, J.G.3
Volpicelli, S.A.4
Huston-Lyons, D.5
Cohen, B.6
-
7
-
-
0028246115
-
Clozapine concentrations in maternal and fetal plasma, amniotic fluid, and breast milk
-
C. Barnas, A. Bergant, M. Hummer, A. Saria, and W.W. Fleischacker Clozapine concentrations in maternal and fetal plasma, amniotic fluid, and breast milk Am. J. Psychiatry 151 1994 945
-
(1994)
Am. J. Psychiatry
, vol.151
, pp. 945
-
-
Barnas, C.1
Bergant, A.2
Hummer, M.3
Saria, A.4
Fleischacker, W.W.5
-
8
-
-
0024358369
-
A rating scale for drug-induced akathisia
-
T. Barnes A rating scale for drug-induced akathisia Br. J. Psychiatry 154 1989 672 676
-
(1989)
Br. J. Psychiatry
, vol.154
, pp. 672-676
-
-
Barnes, T.1
-
9
-
-
0029769679
-
The influence of ethnic factors and gender on CYP1A2-mediated drug disposition: A comparative study in Caucasian and Chinese subjects using phenacetin as a marker substrate
-
A. Bartoli, S. Xiaodong, G. Gatti, G. Cipolla, R. Marchiselli, and E. Perucca The influence of ethnic factors and gender on CYP1A2-mediated drug disposition: a comparative study in Caucasian and Chinese subjects using phenacetin as a marker substrate Ther. Drug Monit. 18 1996 586 591
-
(1996)
Ther. Drug Monit.
, vol.18
, pp. 586-591
-
-
Bartoli, A.1
Xiaodong, S.2
Gatti, G.3
Cipolla, G.4
Marchiselli, R.5
Perucca, E.6
-
10
-
-
0027985726
-
Clozapine disposition covaries with CYP1A2 activity determined by a caffeine test
-
L. Bertilsson, J.A. Carrillo, M.L. Dahl, A. Llerena, C. Alm, U. Bondesson, L. Lindström, I.R. De La Rubia, S. Ramos, and J. Benitez Clozapine disposition covaries with CYP1A2 activity determined by a caffeine test Br. J. Clin. Pharmacol. 38 1994 471 473
-
(1994)
Br. J. Clin. Pharmacol.
, vol.38
, pp. 471-473
-
-
Bertilsson, L.1
Carrillo, J.A.2
Dahl, M.L.3
Llerena, A.4
Alm, C.5
Bondesson, U.6
Lindström, L.7
De La Rubia, I.R.8
Ramos, S.9
Benitez, J.10
-
11
-
-
0019433268
-
Extrapyramidal reactions in Asians
-
R.L. Binder, and R. Levy Extrapyramidal reactions in Asians Am. J. Psychiatry 138 1981 1243 1244
-
(1981)
Am. J. Psychiatry
, vol.138
, pp. 1243-1244
-
-
Binder, R.L.1
Levy, R.2
-
12
-
-
0031903147
-
Effects of caffeine withdrawal from the diet on the metabolism of clozapine in schizophrenic patients
-
J.A. Carrillo, A.G. Herraiz, S.I. Ramos, and J. Benitez Effects of caffeine withdrawal from the diet on the metabolism of clozapine in schizophrenic patients J. Clin. Psychopharmacol. 18 1998 311 316
-
(1998)
J. Clin. Psychopharmacol.
, vol.18
, pp. 311-316
-
-
Carrillo, J.A.1
Herraiz, A.G.2
Ramos, S.I.3
Benitez, J.4
-
13
-
-
0028324887
-
Clozapine and metabolites: Concentration in serum and clinical findings during treatment of chronically psychotic patients
-
F. Centorrino, R.S. Baldessarini, J.C. Kando, F.R. Frankenburg, S.A. Volpicelli, and J.G. Flood Clozapine and metabolites: concentration in serum and clinical findings during treatment of chronically psychotic patients J. Clin. Psychopharmacol. 12 1994 119 125
-
(1994)
J. Clin. Psychopharmacol.
, vol.12
, pp. 119-125
-
-
Centorrino, F.1
Baldessarini, R.S.2
Kando, J.C.3
Frankenburg, F.R.4
Volpicelli, S.A.5
Flood, J.G.6
-
14
-
-
0028052932
-
Serum concentrations clozapine and its major metabolites: Effects of cotreatment with fluoxetine or valproate
-
F. Centorrino, R.S. Baldessarini, J.C. Kando, F.R. Frankenburg, S.A. Volpicelli, F.R. Puopolo, and J.G. Flood Serum concentrations clozapine and its major metabolites: effects of cotreatment with fluoxetine or valproate Am. J. Psychiatry 151 1994 123 125
-
(1994)
Am. J. Psychiatry
, vol.151
, pp. 123-125
-
-
Centorrino, F.1
Baldessarini, R.S.2
Kando, J.C.3
Frankenburg, F.R.4
Volpicelli, S.A.5
Puopolo, F.R.6
Flood, J.G.7
-
15
-
-
0028908644
-
Relation of leukocyte counts during clozapine treatment to serum concentrations of clozapine and metabolites
-
D. Centorrino, R.J. Baldessarini, J.G. Flod, J.C. Kando, and F.R. Frankenburg Relation of leukocyte counts during clozapine treatment to serum concentrations of clozapine and metabolites Am. J. Psychiatry 152 1995 610 612
-
(1995)
Am. J. Psychiatry
, vol.152
, pp. 610-612
-
-
Centorrino, D.1
Baldessarini, R.J.2
Flod, J.G.3
Kando, J.C.4
Frankenburg, F.R.5
-
16
-
-
0029953653
-
Serum levels of clozapine and norclozapine in patients treated with selective serotonin reuptake inhibitors
-
F. Centorrino, R.S. Baldessarini, J.C. Kando, F.R. Frankenburg, S.A. Volpicelli, and J.G. Flood Serum levels of clozapine and norclozapine in patients treated with selective serotonin reuptake inhibitors Am. J. Psychiatry 153 1996 820 822
-
(1996)
Am. J. Psychiatry
, vol.153
, pp. 820-822
-
-
Centorrino, F.1
Baldessarini, R.S.2
Kando, J.C.3
Frankenburg, F.R.4
Volpicelli, S.A.5
Flood, J.G.6
-
17
-
-
0036357464
-
EEG abnormalities during treatment with typical and atypical antipsychotics
-
F. Centorrino, B.H. Price, M. Tuttle, W.M. Bahk, J. Hennen, M.J. Albert, and R.J. Balderrarini EEG abnormalities during treatment with typical and atypical antipsychotics Am. J. Psychiatry 159 2002 109 115
-
(2002)
Am. J. Psychiatry
, vol.159
, pp. 109-115
-
-
Centorrino, F.1
Price, B.H.2
Tuttle, M.3
Bahk, W.M.4
Hennen, J.5
Albert, M.J.6
Balderrarini, R.J.7
-
18
-
-
0030825718
-
Clozapine dosages and plasma concentrations
-
W.H. Chang, S.K. Lin, H.Y. Lane, W.H. Hu, M.W. Jann, and H.N. Lin Clozapine dosages and plasma concentrations J. Formos. Med. Assoc. 96 1997 599 605
-
(1997)
J. Formos. Med. Assoc.
, vol.96
, pp. 599-605
-
-
Chang, W.H.1
Lin, S.K.2
Lane, H.Y.3
Hu, W.H.4
Jann, M.W.5
Lin, H.N.6
-
19
-
-
0026684314
-
Neuroleptic prescription for Chinese schizophrenics in Hong Kong
-
H. Chiu, S. Lee, C.M. Leung, and Y.K. Wing Neuroleptic prescription for Chinese schizophrenics in Hong Kong Aust. N. Z. J. Psychiatry 26 1992 262 264
-
(1992)
Aust. N. Z. J. Psychiatry
, vol.26
, pp. 262-264
-
-
Chiu, H.1
Lee, S.2
Leung, C.M.3
Wing, Y.K.4
-
20
-
-
0031439716
-
Clinical evaluation and plasma clozapine concentrations in Chinese patients with schizophrenia
-
S.A. Chong, C.H. Tan, Y.M. Khoo, H.S. Lee, K.E. Wong, F. Ngui, and M. Winslow Clinical evaluation and plasma clozapine concentrations in Chinese patients with schizophrenia Ther. Drug Monit. 19 1997 219 223
-
(1997)
Ther. Drug Monit.
, vol.19
, pp. 219-223
-
-
Chong, S.A.1
Tan, C.H.2
Khoo, Y.M.3
Lee, H.S.4
Wong, K.E.5
Ngui, F.6
Winslow, M.7
-
21
-
-
0036137824
-
A retrospective study of clozapine and electroencephalographic abnormalities in schizophrenic patients
-
S.J. Chung, S.H. Jeong, Y.M. Ahn, U.G. Kang, Y.J. Koo, J.H. Ha, S.G. Lee, and Y.S. Kim A retrospective study of clozapine and electroencephalographic abnormalities in schizophrenic patients Prog. Neuro-psychopharmacol. Biol. Psychiatry 26 2002 139 144
-
(2002)
Prog. Neuro-psychopharmacol. Biol. Psychiatry
, vol.26
, pp. 139-144
-
-
Chung, S.J.1
Jeong, S.H.2
Ahn, Y.M.3
Kang, U.G.4
Koo, Y.J.5
Ha, J.H.6
Lee, S.G.7
Kim, Y.S.8
-
22
-
-
0033665791
-
A case of pharmacokinetic interference in comedication of clozapine and valproic acid
-
A. Conca, W. Beraus, P. König, and R. Waschgler A case of pharmacokinetic interference in comedication of clozapine and valproic acid Pharmacopsychiatry 33 2000 234 235
-
(2000)
Pharmacopsychiatry
, vol.33
, pp. 234-235
-
-
Conca, A.1
Beraus, W.2
König, P.3
Waschgler, R.4
-
24
-
-
0028307888
-
Disposition of clozapine in man: Lack of association with debrisoquine and S-mephenytoin hydroxylation polymorphism
-
M.L. Dahl, A. Llerena, U. Bondesson, L. Lindström, and L. Bertilsson Disposition of clozapine in man: lack of association with debrisoquine and S-mephenytoin hydroxylation polymorphism Br. J. Clin. Pharmacol. 37 1994 71 74
-
(1994)
Br. J. Clin. Pharmacol.
, vol.37
, pp. 71-74
-
-
Dahl, M.L.1
Llerena, A.2
Bondesson, U.3
Lindström, L.4
Bertilsson, L.5
-
25
-
-
0029950811
-
Elevated clozapine levels after fluvoxamine initiation
-
J.R. Dequardo, and M. Roberts Elevated clozapine levels after fluvoxamine initiation Am. J. Psychiatry 153 1996 840 841
-
(1996)
Am. J. Psychiatry
, vol.153
, pp. 840-841
-
-
Dequardo, J.R.1
Roberts, M.2
-
26
-
-
0033808026
-
Long-term therapeutic drug monitoring of clozapine and metabolites in psychiatric in- and outpatients
-
M. Dettling, C. Sachse, J. Brockmöller, J. Schley, B. Müller-Oerlinghausen, I. Pickersgill, A. Rolfs, R.T. Schaub, and J. Schmider Long-term therapeutic drug monitoring of clozapine and metabolites in psychiatric in- and outpatients Psychopharmacology 152 2000 80 86
-
(2000)
Psychopharmacology
, vol.152
, pp. 80-86
-
-
Dettling, M.1
Sachse, C.2
Brockmöller, J.3
Schley, J.4
Müller- Oerlinghausen, B.5
Pickersgill, I.6
Rolfs, A.7
Schaub, R.T.8
Schmider, J.9
-
27
-
-
0028301156
-
The use of chloral hydrate and sodium amytal during clozapine initiation
-
R.A. Dickson, R. Williams, and T. Dalby The use of chloral hydrate and sodium amytal during clozapine initiation Can. J. Psychiatry 39 1994 132 134
-
(1994)
Can. J. Psychiatry
, vol.39
, pp. 132-134
-
-
Dickson, R.A.1
Williams, R.2
Dalby, T.3
-
28
-
-
0029876905
-
Elevated clozapine plasma concentrations after fluvoxamine initiation
-
G. Dumortier, P. Lochu Am Colen De Melo, O. Ghribi, D. Roche Rabreau, K. Degrassat, and J.M. Desce Elevated clozapine plasma concentrations after fluvoxamine initiation Am. J. Psychiatry 153 1996 738 739
-
(1996)
Am. J. Psychiatry
, vol.153
, pp. 738-739
-
-
Dumortier, G.1
Lochuamcolende Melo, P.2
Ghribi, O.3
Roche Rabreau, D.4
Degrassat, K.5
Desce, J.M.6
-
29
-
-
0030656425
-
The involvement of CYP1A2 and CYP3A4 in the metabolism of clozapine
-
B. Eiermann, G. Engel, I. Johansson, U.M. Zanger, and L. Bertilsson The involvement of CYP1A2 and CYP3A4 in the metabolism of clozapine Br. J. Clin. Pharmacol. 44 1997 439 446
-
(1997)
Br. J. Clin. Pharmacol.
, vol.44
, pp. 439-446
-
-
Eiermann, B.1
Engel, G.2
Johansson, I.3
Zanger, U.M.4
Bertilsson, L.5
-
30
-
-
0036898975
-
Is the time of course of clozapine response correlated to the time course of clozapine plasma levels? a one-year prospective study in drug-resistant patients with schizophrenia
-
M. Fabrazzo, S. La Pia, P. Monteleone, G. Esposito, A. Pinto, L. De Simone, R. Bencivenga, and M. Maj Is the time of course of clozapine response correlated to the time course of clozapine plasma levels? A one-year prospective study in drug-resistant patients with schizophrenia Neuropsychopharmacolgy 27 2002 1050 1055
-
(2002)
Neuropsychopharmacolgy
, vol.27
, pp. 1050-1055
-
-
Fabrazzo, M.1
La Pia, S.2
Monteleone, P.3
Esposito, G.4
Pinto, A.5
De Simone, L.6
Bencivenga, R.7
Maj, M.8
-
31
-
-
0033045133
-
Small effects of valproic acid on the plasma concentrations of clozapine and its major metabolites in patients with schizophrenic or affective disorder
-
G. Facciolà, A. Avenoso, M.G. Scordo, A.G. Madia, A. Ventimiglia, E. Perucca, and E. Spina Small effects of valproic acid on the plasma concentrations of clozapine and its major metabolites in patients with schizophrenic or affective disorder Ther. Drug Monit. 21 1999 341 345
-
(1999)
Ther. Drug Monit.
, vol.21
, pp. 341-345
-
-
Facciolà, G.1
Avenoso, A.2
Scordo, M.G.3
Madia, A.G.4
Ventimiglia, A.5
Perucca, E.6
Spina, E.7
-
32
-
-
0025863392
-
1-acid glycoprotein concentration in Chinese and Caucasian
-
1-acid glycoprotein concentration in Chinese and Caucasian Br. J. Clin. Pharmacol. 31 1991 551 552
-
(1991)
Br. J. Clin. Pharmacol.
, vol.31
, pp. 551-552
-
-
Feely, J.1
Grimm, T.2
-
33
-
-
0028146698
-
Potential impact of valproic acid therapy on clozapine disposition
-
P. Finley, and D. Warner Potential impact of valproic acid therapy on clozapine disposition Biol. Psychiatry 36 1994 487 488
-
(1994)
Biol. Psychiatry
, vol.36
, pp. 487-488
-
-
Finley, P.1
Warner, D.2
-
34
-
-
0030944756
-
Clozapine-induced electroencephalogram changes as a function of clozapine serum levels
-
O. Freudenreich, R.D. Weiner, and J.P. McEvoy Clozapine-induced electroencephalogram changes as a function of clozapine serum levels Biol. Psychiatry 42 1997 132 137
-
(1997)
Biol. Psychiatry
, vol.42
, pp. 132-137
-
-
Freudenreich, O.1
Weiner, R.D.2
McEvoy, J.P.3
-
37
-
-
0006618558
-
-
US Department of Health, Education, and Welfare Washington, DC
-
W. Guy ECDEU Assessment Manual for Psychopharmacology, Publication ADM vols. 76-338 1976 US Department of Health, Education, and Welfare Washington, DC 534 537
-
(1976)
ECDEU Assessment Manual for Psychopharmacology, Publication ADM
, vol.76-338
, pp. 534-537
-
-
Guy, W.1
-
38
-
-
0024468418
-
Dose-related plasma levels of clozapine: Influence of smoking behaviour, sex and age
-
C. Haring, U. Meise, C. Humpel, A. Saria, W.W. Fleischhacker, and H. Hinterhuber Dose-related plasma levels of clozapine: influence of smoking behaviour, sex and age Psychopharmacology 99 1989 S38 S40
-
(1989)
Psychopharmacology
, vol.99
-
-
Haring, C.1
Meise, U.2
Humpel, C.3
Saria, A.4
Fleischhacker, W.W.5
Hinterhuber, H.6
-
39
-
-
0025104037
-
Influence of patient-related variables on clozapine plasma levels
-
C. Haring, W.W. Fleischhacker, P. Schett, C. Humpel, C. Barnas, and A. Saria Influence of patient-related variables on clozapine plasma levels Am. J. Psychiatry 147 1990 1471 1475
-
(1990)
Am. J. Psychiatry
, vol.147
, pp. 1471-1475
-
-
Haring, C.1
Fleischhacker, W.W.2
Schett, P.3
Humpel, C.4
Barnas, C.5
Saria, A.6
-
40
-
-
0028275066
-
EEG alterations in patients treated with clozapine in relation to plasma levels
-
C. Haring, C. Nerdorfer, J. Schwitzer, M. Hummer, A. Saria, H. Hinterhuber, and W.W. Fleischhacker EEG alterations in patients treated with clozapine in relation to plasma levels Psychopharmacology 114 1994 97 100
-
(1994)
Psychopharmacology
, vol.114
, pp. 97-100
-
-
Haring, C.1
Nerdorfer, C.2
Schwitzer, J.3
Hummer, M.4
Saria, A.5
Hinterhuber, H.6
Fleischhacker, W.W.7
-
41
-
-
0027740188
-
Relationship between clinical efficacy and clozapine concentrations in plasma in schizophrenia: Effect of smoking
-
M. Hasegawa, R. Gutierrez-Esteinou, L. Way, and H.Y. Meltzer Relationship between clinical efficacy and clozapine concentrations in plasma in schizophrenia: effect of smoking J. Clin. Psychopharmacol. 13 1993 383 390
-
(1993)
J. Clin. Psychopharmacol.
, vol.13
, pp. 383-390
-
-
Hasegawa, M.1
Gutierrez-Esteinou, R.2
Way, L.3
Meltzer, H.Y.4
-
42
-
-
0035006831
-
Pharmacokinetics of reboxetine in healthy volunteers with different ethnic descents
-
P.E. Hendershot, J.C. Fleishaker, K.M. Lin, I.D. Nuccio, and R.E. Poland Pharmacokinetics of reboxetine in healthy volunteers with different ethnic descents Psychopharmacology 155 2001 148 153
-
(2001)
Psychopharmacology
, vol.155
, pp. 148-153
-
-
Hendershot, P.E.1
Fleishaker, J.C.2
Lin, K.M.3
Nuccio, I.D.4
Poland, R.E.5
-
43
-
-
0030825390
-
A double-blind comparative study of clozapine versus chlorpromazine on Chinese patients with treatment-refractory schizophrenia
-
C.J. Hong, J.Y. Chen, H.J. Chiu, and C.B. Sim A double-blind comparative study of clozapine versus chlorpromazine on Chinese patients with treatment-refractory schizophrenia Int. J. Clin. Psychopharmacol. 12 1997 123 130
-
(1997)
Int. J. Clin. Psychopharmacol.
, vol.12
, pp. 123-130
-
-
Hong, C.J.1
Chen, J.Y.2
Chiu, H.J.3
Sim, C.B.4
-
44
-
-
0024442372
-
Metoprolol and mephenytoin oxidation polymorphisms in Far Eastern Oriental subjects: Japanese versus mainland Chinese
-
Y. Horai, M. Nakano, T. Ishizaki, K. Ishiokawa, H.H. Zhou, B.J. Zhou, C.L. Liao, and L.M. Zhang Metoprolol and mephenytoin oxidation polymorphisms in Far Eastern Oriental subjects: Japanese versus mainland Chinese Clin. Pharmacol. Ther. 46 1989 198 207
-
(1989)
Clin. Pharmacol. Ther.
, vol.46
, pp. 198-207
-
-
Horai, Y.1
Nakano, M.2
Ishizaki, T.3
Ishiokawa, K.4
Zhou, H.H.5
Zhou, B.J.6
Liao, C.L.7
Zhang, L.M.8
-
45
-
-
0023812652
-
Clozapine for the treatment-resistant schizophrenic: A double-blind comparison with chlorpromazine
-
J. Kane, G. Honigfeld, J. Singer, and H. Meltzer Clozapine for the treatment-resistant schizophrenic: a double-blind comparison with chlorpromazine Arch. Gen. Psychiatry 45 1988 789 796
-
(1988)
Arch. Gen. Psychiatry
, vol.45
, pp. 789-796
-
-
Kane, J.1
Honigfeld, G.2
Singer, J.3
Meltzer, H.4
-
46
-
-
0028089729
-
Clozapine, negative symptoms and extrapyramidal side effects
-
J.M. Kane, A.Z. Safferman, S. Pollack, C. Johns, S. Szymanski, M. Kronig, and J.A. Lieberman Clozapine, negative symptoms and extrapyramidal side effects J. Clin. Psychiatry 55 9, Suppl. B 1994 74 77
-
(1994)
J. Clin. Psychiatry
, vol.55
, Issue.9 SUPPL. B
, pp. 74-77
-
-
Kane, J.M.1
Safferman, A.Z.2
Pollack, S.3
Johns, C.4
Szymanski, S.5
Kronig, M.6
Lieberman, J.A.7
-
47
-
-
0034799836
-
Clozapine and haloperidol in moderately refractory schizophrenia
-
J.M. Kane, S.R. Marder, N.R. Schooler, W.C. Wirshing, D. Umbricht, R.W. Baker, D.A. Wirshing, A. Safferman, R. Ganguli, M. McMeniman, and M. Borenstein Clozapine and haloperidol in moderately refractory schizophrenia Arch. Gen. Psychiatry 58 2001 965 972
-
(2001)
Arch. Gen. Psychiatry
, vol.58
, pp. 965-972
-
-
Kane, J.M.1
Marder, S.R.2
Schooler, N.R.3
Wirshing, W.C.4
Umbricht, D.5
Baker, R.W.6
Wirshing, D.A.7
Safferman, A.8
Ganguli, R.9
McMeniman, M.10
Borenstein, M.11
-
48
-
-
0030025732
-
Triazolam pharmacokinetics and pharmacodynamics in Caucasians and Southern Asians: Ethnicity and CYP3A activity
-
M.T. Kinirons, C.C. Lang, H.B. He, K. Gherbresekasie, S. Shay, D.W. Robin, and A.J.J. Wood Triazolam pharmacokinetics and pharmacodynamics in Caucasians and Southern Asians: ethnicity and CYP3A activity Br. J. Clin. Pharmacol. 41 1996 69 72
-
(1996)
Br. J. Clin. Pharmacol.
, vol.41
, pp. 69-72
-
-
Kinirons, M.T.1
Lang, C.C.2
He, H.B.3
Gherbresekasie, K.4
Shay, S.5
Robin, D.W.6
Wood, A.J.J.7
-
51
-
-
0028877764
-
Plasma clozapine levels and clinical response for treatment-refractory schizophrenic patients
-
M.H. Kronig, R.A. Munne, S. Szymanski, A.Z. Safferman, S. Pollack, T. Cooper, J.M. Kane, and J.A. Lieberman Plasma clozapine levels and clinical response for treatment-refractory schizophrenic patients Am. J. Psychiatry 152 1995 179 182
-
(1995)
Am. J. Psychiatry
, vol.152
, pp. 179-182
-
-
Kronig, M.H.1
Munne, R.A.2
Szymanski, S.3
Safferman, A.Z.4
Pollack, S.5
Cooper, T.6
Kane, J.M.7
Lieberman, J.A.8
-
52
-
-
0032918565
-
Coadministration of clozapine and fluvoxamine in psychotic patients-clinical experience
-
C.H. Lammers, M. Deuschle, H. Weigmann, S. Härtter, C. Hiemke, C. Heese, and I. Heuser Coadministration of clozapine and fluvoxamine in psychotic patients-clinical experience Pharmacopsychiatry 32 1999 76 77
-
(1999)
Pharmacopsychiatry
, vol.32
, pp. 76-77
-
-
Lammers, C.H.1
Deuschle, M.2
Weigmann, H.3
Härtter, S.4
Hiemke, C.5
Heese, C.6
Heuser, I.7
-
53
-
-
0035196163
-
Repeated ingestion of grapefruit juice does not alter clozapine's steady-state plasma levels, effectiveness, and tolerability
-
H.Y. Lane, M.W. Jann, Y.C. Chang, C.C. Chiu, M.C. Huang, S.H. Lee, and W.H. Chang Repeated ingestion of grapefruit juice does not alter clozapine's steady-state plasma levels, effectiveness, and tolerability J. Clin. Psychiatry 62 2001 812 817
-
(2001)
J. Clin. Psychiatry
, vol.62
, pp. 812-817
-
-
Lane, H.Y.1
Jann, M.W.2
Chang, Y.C.3
Chiu, C.C.4
Huang, M.C.5
Lee, S.H.6
Chang, W.H.7
-
54
-
-
0028007550
-
Clinical effects of clozapine in chronic schizophrenia: Response to treatment and predictors of outcome
-
J.A. Lieberman, A.Z. Safferman, S. Pollack, S. Szymanski, C. Johns, A. Howard, M. Kronig, P. Bookstein, and J.M. Kane Clinical effects of clozapine in chronic schizophrenia: response to treatment and predictors of outcome Am. J. Psychiatry 151 1994 1744 1752
-
(1994)
Am. J. Psychiatry
, vol.151
, pp. 1744-1752
-
-
Lieberman, J.A.1
Safferman, A.Z.2
Pollack, S.3
Szymanski, S.4
Johns, C.5
Howard, A.6
Kronig, M.7
Bookstein, P.8
Kane, J.M.9
-
55
-
-
0020597567
-
Neuroleptic dosage for Asians
-
K.M. Lin, and E. Finder Neuroleptic dosage for Asians Am. J. Psychiatry 140 1983 490 491
-
(1983)
Am. J. Psychiatry
, vol.140
, pp. 490-491
-
-
Lin, K.M.1
Finder, E.2
-
57
-
-
0024435931
-
Longitudinal assessment of haloperidol dosage and serum concentration in Asian and Caucasian schizophrenic patients
-
K.M. Lin, R.E. Poland, J. Lau, I. Nuccio, K. Matsuda, N. Hathuc, T. Su, and P. fu Longitudinal assessment of haloperidol dosage and serum concentration in Asian and Caucasian schizophrenic patients Am. J. Psychiatry 146 1989 1307 1311
-
(1989)
Am. J. Psychiatry
, vol.146
, pp. 1307-1311
-
-
Lin, K.M.1
Poland, R.E.2
Lau, J.3
Nuccio, I.4
Matsuda, K.5
Hathuc, N.6
Su, T.7
Fu, P.8
-
58
-
-
0036246398
-
Effectiveness of clozapine in neuroleptic-resistant schizophrenia: Clinical response and plasma concentrations
-
P.M. Llorca, C. Lancon, B. Disdier, J. Farisee, C. Sapin, and P. Auquier Effectiveness of clozapine in neuroleptic-resistant schizophrenia: clinical response and plasma concentrations J. Psychiatry Neurosci. 27 2002 30 37
-
(2002)
J. Psychiatry Neurosci.
, vol.27
, pp. 30-37
-
-
Llorca, P.M.1
Lancon, C.2
Disdier, B.3
Farisee, J.4
Sapin, C.5
Auquier, P.6
-
59
-
-
0028917675
-
Valproic acid effects on serum concentrations of clozapine and norclozapine
-
L.P. Longo, and C. Salzman Valproic acid effects on serum concentrations of clozapine and norclozapine Am. J. Psychiatry 153 1995 650
-
(1995)
Am. J. Psychiatry
, vol.153
, pp. 650
-
-
Longo, L.P.1
Salzman, C.2
-
60
-
-
84920227522
-
Low frequency of slow debrisoquine hydroxylation in a native Chinese population
-
Y.C. Lou, L. Ying, L. Bertilsson, and F. Sjöqvist Low frequency of slow debrisoquine hydroxylation in a native Chinese population Lancet 10 1987 852 853
-
(1987)
Lancet
, vol.10
, pp. 852-853
-
-
Lou, Y.C.1
Ying, L.2
Bertilsson, L.3
Sjöqvist, F.4
-
61
-
-
0033861422
-
Fluvoxamine reduces the clozapine dosage needed in refractory schizophrenic patients
-
M.L. Lu, H.Y. Lane, K.P. Chen, M.W. Jann, M.H. Su, and W.H. Chang Fluvoxamine reduces the clozapine dosage needed in refractory schizophrenic patients J. Clin. Psychiatry 61 2000 594 599
-
(2000)
J. Clin. Psychiatry
, vol.61
, pp. 594-599
-
-
Lu, M.L.1
Lane, H.Y.2
Chen, K.P.3
Jann, M.W.4
Su, M.H.5
Chang, W.H.6
-
62
-
-
0001190858
-
Appendix A. Manual for expanded for brief psychiatric rating scale (BPRS)
-
D. Lukoff, K.H. Nuechterlein, and J. Ventura Appendix A. Manual for expanded for brief psychiatric rating scale (BPRS) Schizophr. Bull. 12 1986 594 602
-
(1986)
Schizophr. Bull.
, vol.12
, pp. 594-602
-
-
Lukoff, D.1
Nuechterlein, K.H.2
Ventura, J.3
-
63
-
-
9344235447
-
Clozapine dosage, serum levels, efficacy, and side-effect profiles: A comparison of Korean-American and Caucasian patients
-
K.T. Matsuda, C.C. Man, M.L. Keg, M.W. Smith, A.S. Young, and J.A. Adams Clozapine dosage, serum levels, efficacy, and side-effect profiles: a comparison of Korean-American and Caucasian patients Psychopharmacol. Bull. 32 1996 253 257
-
(1996)
Psychopharmacol. Bull.
, vol.32
, pp. 253-257
-
-
Matsuda, K.T.1
Man, C.C.2
Keg, M.L.3
Smith, M.W.4
Young, A.S.5
Adams, J.A.6
-
64
-
-
33644536327
-
-
J. Mckenzie, L. Sweeting, S.J. Lai, and R. Lerner Use of REMEDi HS for Therapeutic Monitoring of Clozapine and Norclozapine. Presented at the American Association of Clinical Chemistry (AACC) Conference, July 28, 1999, New Orleans 1999
-
(1999)
Use of REMEDi HS for Therapeutic Monitoring of Clozapine and Norclozapine. Presented at the American Association of Clinical Chemistry (AACC) Conference, July 28, 1999, New Orleans
-
-
McKenzie, J.1
Sweeting, L.2
Lai, S.J.3
Lerner, R.4
-
65
-
-
0024443178
-
A prospective study of clozapine in treatment-resistant schizophrenic patients I. Preliminary report
-
H.Y. Meltzer, B. Bastani, K.K. Young, L.F. Bamirez, S. Burnett, and J. Sharpe A prospective study of clozapine in treatment-resistant schizophrenic patients I. Preliminary report Psychopharmacology 99 1989 S68 S72
-
(1989)
Psychopharmacology
, vol.99
-
-
Meltzer, H.Y.1
Bastani, B.2
Young, K.K.3
Bamirez, L.F.4
Burnett, S.5
Sharpe, J.6
-
66
-
-
0035195730
-
Individual changes in clozapine levels after smoking cessation: Results and a predictive model
-
J.M. Meyer Individual changes in clozapine levels after smoking cessation: results and a predictive model J. Clin. Psychopharmacol. 21 2001 569 574
-
(2001)
J. Clin. Psychopharmacol.
, vol.21
, pp. 569-574
-
-
Meyer, J.M.1
-
67
-
-
0026078295
-
Effect of phenytoin on plasma clozapine concentrations in two patients
-
D.D. Miller Effect of phenytoin on plasma clozapine concentrations in two patients J. Clin. Psychiatry 52 1991 23 25
-
(1991)
J. Clin. Psychiatry
, vol.52
, pp. 23-25
-
-
Miller, D.D.1
-
68
-
-
0027937972
-
Plasma clozapine concentrations as a predictor of clinical response: A follow-up study
-
D.D. Miller, P. Fleming, and T.L. Holman Plasma clozapine concentrations as a predictor of clinical response: a follow-up study J. Clin. Psychiatry 55 1994 117 121
-
(1994)
J. Clin. Psychiatry
, vol.55
, pp. 117-121
-
-
Miller, D.D.1
Fleming, P.2
Holman, T.L.3
-
69
-
-
0022178173
-
Interethnic differences in genetic polymorphism of debrisoquin and mephenytoin hydroxylation between Japanese and Caucasian populations
-
K. Nakamura, F. Goto, W.A. Ray, C.B. McAllister, E. Jacqz, G.R. Wilkinson, and R.A. Branch Interethnic differences in genetic polymorphism of debrisoquin and mephenytoin hydroxylation between Japanese and Caucasian populations Clin. Pharmacol. Ther. 38 1985 402 408
-
(1985)
Clin. Pharmacol. Ther.
, vol.38
, pp. 402-408
-
-
Nakamura, K.1
Goto, F.2
Ray, W.A.3
McAllister, C.B.4
Jacqz, E.5
Wilkinson, G.R.6
Branch, R.A.7
-
70
-
-
0029617261
-
CSF and serum concentrations of clozapine and its demethyl metabolite: A pilot study
-
C. Nordin, B. Almé, and U. Bondesson CSF and serum concentrations of clozapine and its demethyl metabolite: a pilot study Psychopharmacology 122 1995 104 107
-
(1995)
Psychopharmacology
, vol.122
, pp. 104-107
-
-
Nordin, C.1
Almé, B.2
Bondesson, U.3
-
72
-
-
0028897012
-
Clozapine serum levels and side effects during steady state treatment of schizophrenic patients: A cross-sectional study
-
O.V. Olesen, K. Thomsen, P.N. Jensen, C.H. Wulff, N.A. Rasmussen, C. Refshammer, J. Sorensen, M. Bysted, J. Christnesen, and R. Rosenberg Clozapine serum levels and side effects during steady state treatment of schizophrenic patients: a cross-sectional study Psychopharmacology 117 1995 371 378
-
(1995)
Psychopharmacology
, vol.117
, pp. 371-378
-
-
Olesen, O.V.1
Thomsen, K.2
Jensen, P.N.3
Wulff, C.H.4
Rasmussen, N.A.5
Refshammer, C.6
Sorensen, J.7
Bysted, M.8
Christnesen, J.9
Rosenberg, R.10
-
73
-
-
0036277478
-
Relation of blood counts during clozapine treatment to serum concentrations of clozapine and nor-clozapine
-
L.K. Oyewumi, Z.Z. Cernovsky, D.J. Freeman, and D.L. Streiner Relation of blood counts during clozapine treatment to serum concentrations of clozapine and nor-clozapine Can. J. Psychiatry 47 2002 257 261
-
(2002)
Can. J. Psychiatry
, vol.47
, pp. 257-261
-
-
Oyewumi, L.K.1
Cernovsky, Z.Z.2
Freeman, D.J.3
Streiner, D.L.4
-
74
-
-
0034922215
-
CYP1A2 activity as measured by a caffeine test predicts clozapine and active metabolite norclozapine steady-state concentration in patients with schizophrenia
-
V. Özdemir, W. Kalow, P. Posner, E.J. Collins, J.L. Kennedy, B.K. Tang, L.J. Albers, C. Reist, R. Roy, W. Walkes, and P. Afra CYP1A2 activity as measured by a caffeine test predicts clozapine and active metabolite norclozapine steady-state concentration in patients with schizophrenia J. Clin. Psychopharmacol. 21 2001 398 407
-
(2001)
J. Clin. Psychopharmacol.
, vol.21
, pp. 398-407
-
-
Özdemir, V.1
Kalow, W.2
Posner, P.3
Collins, E.J.4
Kennedy, J.L.5
Tang, B.K.6
Albers, L.J.7
Reist, C.8
Roy, R.9
Walkes, W.10
Afra, P.11
-
75
-
-
0026068791
-
Clozapine and norclozapine plasma concentrations and clinical response of treatment-refractory schizophrenic patients
-
P.J. Perry, D.D. Miller, S.V. Arndt, and R.J. Cadoret Clozapine and norclozapine plasma concentrations and clinical response of treatment-refractory schizophrenic patients Am. J. Psychiatry 148 1991 231 235
-
(1991)
Am. J. Psychiatry
, vol.148
, pp. 231-235
-
-
Perry, P.J.1
Miller, D.D.2
Arndt, S.V.3
Cadoret, R.J.4
-
76
-
-
0032532712
-
Relationship between patient variables and plasma clozapine concentrations: A dosing nomogram
-
P.J. Perry, K.A. Bever, S. Arndt, and M.D. Combs Relationship between patient variables and plasma clozapine concentrations: a dosing nomogram Biol. Psychiatry 434 1998 733 738
-
(1998)
Biol. Psychiatry
, vol.434
, pp. 733-738
-
-
Perry, P.J.1
Bever, K.A.2
Arndt, S.3
Combs, M.D.4
-
77
-
-
0026772116
-
Clinical and biologic response to clozapine in patients with schizophrenia. Crossover comparison with fluphenazine
-
D. Pickar, R.R. Owen, R.E. Litman, E. Konicki, R. Guterrez, and M.H. Rapaport Clinical and biologic response to clozapine in patients with schizophrenia. Crossover comparison with fluphenazine Arch. Gen. Psychiatry 49 1992 345 353
-
(1992)
Arch. Gen. Psychiatry
, vol.49
, pp. 345-353
-
-
Pickar, D.1
Owen, R.R.2
Litman, R.E.3
Konicki, E.4
Guterrez, R.5
Rapaport, M.H.6
-
78
-
-
0028944753
-
Metabolism and bioactivation of clozapine by human liver in vitro
-
M. Pirohamed, D. Williams, S. Madden, E. Templeton, and B.K. Park Metabolism and bioactivation of clozapine by human liver in vitro J. Pharmacol. Exp. Ther. 272 1995 984 990
-
(1995)
J. Pharmacol. Exp. Ther.
, vol.272
, pp. 984-990
-
-
Pirohamed, M.1
Williams, D.2
Madden, S.3
Templeton, E.4
Park, B.K.5
-
79
-
-
0027942064
-
Plasma clozapine concentrations predict clinical response in treatment-resistant schizophrenia
-
S.G. Potkin, R. Bera, B. Gulasekaram, J. Costa, S. Hayes, Y. Jin, G. Richmond, D. Carrenon, K. Sitanggan, B. Gerber, J. Telford, L. Plon, H. Plon, L. Park, J. Chang, J. Oldroyd, and T. Cooper Plasma clozapine concentrations predict clinical response in treatment-resistant schizophrenia J. Clin. Psychiatry 55 Suppl. B 1994 133 136
-
(1994)
J. Clin. Psychiatry
, vol.55
, Issue.SUPPL. B
, pp. 133-136
-
-
Potkin, S.G.1
Bera, R.2
Gulasekaram, B.3
Costa, J.4
Hayes, S.5
Jin, Y.6
Richmond, G.7
Carrenon, D.8
Sitanggan, K.9
Gerber, B.10
Telford, J.11
Plon, L.12
Plon, H.13
Park, L.14
Chang, J.15
Oldroyd, J.16
Cooper, T.17
-
81
-
-
0033378177
-
How long to wait for a response to clozapine: A comparison of time course of response to clozapine and conventional antipsychotic medication in refractory schizophrenia
-
R. Rosenheck, D. Evans, L. Herz, J. Cramer, W. Xu, J. Thomas, W. Henderson, and D. Charney How long to wait for a response to clozapine: a comparison of time course of response to clozapine and conventional antipsychotic medication in refractory schizophrenia Schizophr. Bull. 25 1999 709 719
-
(1999)
Schizophr. Bull.
, vol.25
, pp. 709-719
-
-
Rosenheck, R.1
Evans, D.2
Herz, L.3
Cramer, J.4
Xu, W.5
Thomas, J.6
Henderson, W.7
Charney, D.8
-
82
-
-
0032897189
-
Impact of clozapine on negative symptoms and on the deficit syndrome in refractory schizophrenia
-
and the Department of Veterans Affairs Cooperative Study Group on Clozapine in Refractory Schizophrenia D.
-
R. Rosenheck, L. Dunn, M. Peszke, J. Cramer, W. Xu, J. Thomas, D. Charney and the Department of Veterans Affairs Cooperative Study Group on Clozapine in Refractory Schizophrenia Impact of clozapine on negative symptoms and on the deficit syndrome in refractory schizophrenia Am. J. Psychiatry 156 1999 88 93
-
(1999)
Am. J. Psychiatry
, vol.156
, pp. 88-93
-
-
Rosenheck, R.1
Dunn, L.2
Peszke, M.3
Cramer, J.4
Xu, W.5
Thomas, J.6
Charney7
-
83
-
-
0001851257
-
The UKU side effect's rating scale
-
Scandinavian Society of Psychopharmacology Committee of Clinical Investigations (UKU) The UKU side effect's rating scale Acta Psychiatr. Scand. 334 1987 81 100 (Suppl.)
-
(1987)
Acta Psychiatr. Scand.
, vol.334
, pp. 81-100
-
-
-
84
-
-
0032711713
-
Clozapine serum concentrations are lower in smoking than in non-smoking schizophrenic patients
-
N.H. Seppälä, E.V.J. Leinonen, M.L. Lehtonen, and K.T. Kivist Clozapine serum concentrations are lower in smoking than in non-smoking schizophrenic patients Pharmacol. Toxicol. 85 1999 244 246
-
(1999)
Pharmacol. Toxicol.
, vol.85
, pp. 244-246
-
-
Seppälä, N.H.1
Leinonen, E.V.J.2
Lehtonen, M.L.3
Kivist, K.T.4
-
85
-
-
48249153186
-
Intraclass correlations: Uses in assessing rater reliability
-
P.E. Shrout, and J.L. Fleiss Intraclass correlations: uses in assessing rater reliability Psychol. Bull. 86 1979 420 428
-
(1979)
Psychol. Bull.
, vol.86
, pp. 420-428
-
-
Shrout, P.E.1
Fleiss, J.L.2
-
86
-
-
0014723449
-
A rating scale for extrapyramidal side effects
-
G. Simpson, and J.S.W. Angus A rating scale for extrapyramidal side effects Acta Psychiatr. Scand. 212 1970 9 11 (Suppl.)
-
(1970)
Acta Psychiatr. Scand.
, vol.212
, pp. 9-11
-
-
Simpson, G.1
Angus, J.S.W.2
-
87
-
-
0002310994
-
Relationship between plasma concentrations of clozapine and norclozapine and therapeutic response in patients with schizophrenia resistant to conventional neuroleptics
-
E. Spina, A. Avenoso, G. Facciolä, M.G. Scordo, M. Ancione, A.G. Madia, A. Ventimiglia, and E. Perucca Relationship between plasma concentrations of clozapine and norclozapine and therapeutic response in patients with schizophrenia resistant to conventional neuroleptics Psychopharmacology 148 2000 83 89
-
(2000)
Psychopharmacology
, vol.148
, pp. 83-89
-
-
Spina, E.1
Avenoso, A.2
Facciolä, G.3
Scordo, M.G.4
Ancione, M.5
Madia, A.G.6
Ventimiglia, A.7
Perucca, E.8
-
88
-
-
0022569655
-
Neuroleptic dosage for Asians: A failure to replicate
-
J.J. Sramek, M.A. Sayles, and G.M. Simpson Neuroleptic dosage for Asians: a failure to replicate Am. J. Psychiatry 153 1986 535 536
-
(1986)
Am. J. Psychiatry
, vol.153
, pp. 535-536
-
-
Sramek, J.J.1
Sayles, M.A.2
Simpson, G.M.3
-
89
-
-
0028925217
-
Improved efficacy and fewer side effects under clozapine treatment after addition of fluvoxamine
-
A. Szegedi, J. Wiesner, and C. Hiemke Improved efficacy and fewer side effects under clozapine treatment after addition of fluvoxamine J. Clin. Psychopharmacol. 15 1995 141 143
-
(1995)
J. Clin. Psychopharmacol.
, vol.15
, pp. 141-143
-
-
Szegedi, A.1
Wiesner, J.2
Hiemke, C.3
-
90
-
-
0032863283
-
Addition of low-dose fluvoxamine to low-dose clozapine monotherapy in schizophrenia: Drug monitoring and tolerability data from a prospective clinical trial
-
A. Szegedi, I. Anghelescu, J. Wiesner, S. Schlegel, H. Weigmann, S. Härtter, C. Hiemke, and H. Wetzel Addition of low-dose fluvoxamine to low-dose clozapine monotherapy in schizophrenia: drug monitoring and tolerability data from a prospective clinical trial Pharmacopsychiatry 32 1999 148 153
-
(1999)
Pharmacopsychiatry
, vol.32
, pp. 148-153
-
-
Szegedi, A.1
Anghelescu, I.2
Wiesner, J.3
Schlegel, S.4
Weigmann, H.5
Härtter, S.6
Hiemke, C.7
Wetzel, H.8
-
91
-
-
0027483444
-
Clinical evaluation and serum concentration of zuclopenthixol acetate in psychotic Asian patients; A single-dose preliminary study
-
C.H. Tan, B.I. Low, L.L. Ng, Y.M. Khoo, and H.S. Lee Clinical evaluation and serum concentration of zuclopenthixol acetate in psychotic Asian patients; a single-dose preliminary study Ther. Drug Monit. 15 1993 108 112
-
(1993)
Ther. Drug Monit.
, vol.15
, pp. 108-112
-
-
Tan, C.H.1
Low, B.I.2
Ng, L.L.3
Khoo, Y.M.4
Lee, H.S.5
-
92
-
-
0017330153
-
Clozapine treatment of schizophrenic patients: Plasma concentration and coagulation factors
-
M. Thorup, and R. Fog Clozapine treatment of schizophrenic patients: plasma concentration and coagulation factors Acta Psychiatr. Scand. 66 1977 123 126
-
(1977)
Acta Psychiatr. Scand.
, vol.66
, pp. 123-126
-
-
Thorup, M.1
Fog, R.2
-
93
-
-
0029906397
-
EEG abnormalities in clozapine-treated schizophrenia patients
-
I.A. Treves, and M.Y. Neufeld EEG abnormalities in clozapine-treated schizophrenia patients Eur. Neuropsychopharmacol. 6 1996 93 94
-
(1996)
Eur. Neuropsychopharmacol.
, vol.6
, pp. 93-94
-
-
Treves, I.A.1
Neufeld, M.Y.2
-
94
-
-
0026441418
-
Drug distribution between blood and brain as a determinant of antipsychotic drug effects
-
T. Tsuneizumi, S.M. Babb, and B.M. Cohen Drug distribution between blood and brain as a determinant of antipsychotic drug effects Biol. Psychiatry 32 1992 817 824
-
(1992)
Biol. Psychiatry
, vol.32
, pp. 817-824
-
-
Tsuneizumi, T.1
Babb, S.M.2
Cohen, B.M.3
-
95
-
-
0032955464
-
Characterization of the human hepatic cytochromes P450 involved in the in vitro oxidation of clozapine
-
M. Tugnait, E.M. Hawes, G. McKay, M. Eichelbaum, and K.K. Midha Characterization of the human hepatic cytochromes P450 involved in the in vitro oxidation of clozapine Chem.-Biol. Interact. 118 1999 171 189
-
(1999)
Chem.-Biol. Interact.
, vol.118
, pp. 171-189
-
-
Tugnait, M.1
Hawes, E.M.2
McKay, G.3
Eichelbaum, M.4
Midha, K.K.5
-
96
-
-
0037339287
-
The effect of smoking and cytochrome P450 CYP1A2 genetic polymorphism on clozapine clearance and dose requirement
-
J. Van der Weide, L.S.W. Steijns, and M.J.M. Van Weelden The effect of smoking and cytochrome P450 CYP1A2 genetic polymorphism on clozapine clearance and dose requirement Pharmacogenetics 13 2003 169 172
-
(2003)
Pharmacogenetics
, vol.13
, pp. 169-172
-
-
Van Der Weide, J.1
Steijns, L.S.W.2
Van Weelden, M.J.M.3
-
97
-
-
0029903903
-
Response of patients with treatment-resistant schizophrenia to clozapine within three serum level ranges
-
C. VanderZwaag, M. McGee, J.P. McEvoy, O. Freudenreich, W.H. Wilson, and T.B. Cooper Response of patients with treatment-resistant schizophrenia to clozapine within three serum level ranges Am. J. Psychiatry 153 1996 1579 1584
-
(1996)
Am. J. Psychiatry
, vol.153
, pp. 1579-1584
-
-
Vanderzwaag, C.1
McGee, M.2
McEvoy, J.P.3
Freudenreich, O.4
Wilson, W.H.5
Cooper, T.B.6
-
98
-
-
0344141457
-
Distribution of clozapine and desmethylclozapine between blood and brain in rats
-
H. Weigmann, S. Härtter, V. Fischer, N. Dahmen, and C. Hiemke Distribution of clozapine and desmethylclozapine between blood and brain in rats Eur. Neuropsychopharmacol. 9 1999 253 256
-
(1999)
Eur. Neuropsychopharmacol.
, vol.9
, pp. 253-256
-
-
Weigmann, H.1
Härtter, S.2
Fischer, V.3
Dahmen, N.4
Hiemke, C.5
-
100
-
-
0029899665
-
Time required for initial improvement during clozapine treatment of refractory schizophrenia
-
W.H. Wilson Time required for initial improvement during clozapine treatment of refractory schizophrenia Am. J. Psychiatry 153 1996 951 952
-
(1996)
Am. J. Psychiatry
, vol.153
, pp. 951-952
-
-
Wilson, W.H.1
-
101
-
-
0034834561
-
Ethnic differences and relationships in the oral pharmacokinetics of nifedipine and erythromycin
-
K.S. Yu, J.Y. Cho, J.H. Shon, K.S. Bae, S.Y. Yi, H.S. Lim, I.J. Jang, and S.G. Shin Ethnic differences and relationships in the oral pharmacokinetics of nifedipine and erythromycin Clin. Pharmacol. Ther. 70 2001 228 236
-
(2001)
Clin. Pharmacol. Ther.
, vol.70
, pp. 228-236
-
-
Yu, K.S.1
Cho, J.Y.2
Shon, J.H.3
Bae, K.S.4
Yi, S.Y.5
Lim, H.S.6
Jang, I.J.7
Shin, S.G.8
-
102
-
-
0025326592
-
Differences in plasma binding of drugs between Caucasians and Chinese subjects
-
H.H. Zhou, A. Adedoyin, and G.R. Wilkinson Differences in plasma binding of drugs between Caucasians and Chinese subjects Pharmacokinet. Drug Dispos. 48 1990 10 17
-
(1990)
Pharmacokinet. Drug Dispos.
, vol.48
, pp. 10-17
-
-
Zhou, H.H.1
Adedoyin, A.2
Wilkinson, G.R.3
|